Wordt geladen...
PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking
l-DOPA–induced dyskinesia (LID), a detrimental consequence of dopamine replacement therapy for Parkinson’s disease, is associated with an alteration in dopamine D1 receptor (D1R) and glutamate receptor interactions. We hypothesized that the synaptic scaffolding protein PSD-95 plays a pivotal role in...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Clinical Investigation
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3484432/ https://ncbi.nlm.nih.gov/pubmed/23041629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI59426 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|